mhc ii Search Results


90
R&D Systems anti mhc class i
Anti Mhc Class I, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mhc class i/product/R&D Systems
Average 90 stars, based on 1 article reviews
anti mhc class i - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Bio-Rad mouse anti mhc ii
Mouse Anti Mhc Ii, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti mhc ii/product/Bio-Rad
Average 93 stars, based on 1 article reviews
mouse anti mhc ii - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc mhcii lgii 612 14 68258s
Mhcii Lgii 612 14 68258s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mhcii lgii 612 14 68258s/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
mhcii lgii 612 14 68258s - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Cytek Biosciences apc cyanine7 anti mouse mhc class ii i a i e
Apc Cyanine7 Anti Mouse Mhc Class Ii I A I E, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc cyanine7 anti mouse mhc class ii i a i e/product/Cytek Biosciences
Average 90 stars, based on 1 article reviews
apc cyanine7 anti mouse mhc class ii i a i e - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Cytek Biosciences mhcii pe cy7
Mhcii Pe Cy7, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mhcii pe cy7/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
mhcii pe cy7 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Proteintech hla dra
M1-like macrophages secrete CXCL16 and support CXCR6 + CD8 + T-cell recruitment but are progressively lost during PCa progression. ( A ) UMAP plot of tumor-infiltrating myeloid cells from PCa tissues, identifying five distinct clusters, including an IL1B + macrophage subset. ( B ) Dot plot showing average expression and detection frequency of selected marker genes across macrophage and dendritic cell (DC) clusters. ( C ) Violin plots illustrating the expression of key pro-inflammatory ( IL1B , TLR2 , CD86 ), anti-inflammatory ( CD163 , MRC1 ), and chemokine ( CXCL16 ) genes across myeloid subsets. ( D ) AUCell-based quantification of M1 and M2 gene signatures across clusters; IL1B + macrophages exhibit the highest M1 signature score. Kruskal-Wallis test, ****p<0.0001. ( E ) CellChat network visualizing outgoing macrophage-derived signals to CD8 + T-cell subsets; IL1B + macrophages prominently interact with CXCR6 + TEff-like CD8 + T cells. ( F ) Bubble plot visualizing the results of ligand–receptor interaction analysis; CXCL16–CXCR6 axis ranks among the strongest predicted signals. ( G ) Gating strategy for the identification of murine bone marrow-derived macrophages (BMDMs) induced with M-CSF. ( H ) Flow cytometry of BMDMs polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by CD80 and CD206 expression. ( I ) Confocal images of THP-1-derived macrophages stained for CD68 after PMA induction. ( J ) Flow cytometry of THP-1-derived macrophages polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by MHC-II and CD206 expression. ( K ) Immunoblots showing higher CXCL16 levels in M1-polarized BMDMs compared with their M2 counterparts. ( L ) ELISA quantification of secreted CXCL16 in the supernatants of M1-polarized and M2-polarized THP-1-derived macrophages. Mann-Whitney U test, **p<0.01. ( M ) Immunoblot analysis demonstrating elevated levels of CXCL16 in M1-polarized THP-1-derived macrophages compared with M2-polarized cells. (N, O). A total of 5×10⁶ TRAMP-C1 cells suspended in 100 µL PBS were subcutaneously implanted into the right flank of 5–6-week-old male WT C57BL/6J mice (n=5 per group). Tumors were harvested at day 35 (early stage) and day 49 (advanced stage) post-inoculation. Flow cytometric analysis of TAMs revealed a significant reduction in the ratio of MHCII + CD206⁻ (M1-like) to MHCII⁻ CD206 + (M2-like) macrophages during tumor progression. Mann-Whitney U test, **p<0.01. ( P ) Multiplex immunohistochemistry of human PCa tissues (GS=3+4 vs GS=5+5) demonstrated spatial proximity between CXCL16 + M1-like macrophages <t>(HLA-DRA</t> + ) and CXCR6 + CD8 + T cells in lower-grade (GS=3+4) tumors, which was largely diminished in high-grade (GS=5+5) lesions. Black arrows indicate matched regions across serial tissue sections. Scale bars: upper panels, 100 µm; lower panels, 40 µm. AUCell, area under the recovery curve; GS, Gleason Score; M-CSF, macrophage colony-stimulating factor; PCa, prostate cancer; PBS, phosphate-buffered saline; TAMs, tumor-associated macrophages.
Hla Dra, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla dra/product/Proteintech
Average 94 stars, based on 1 article reviews
hla dra - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology rat anti mouse mhc class ii monoclonal
M1-like macrophages secrete CXCL16 and support CXCR6 + CD8 + T-cell recruitment but are progressively lost during PCa progression. ( A ) UMAP plot of tumor-infiltrating myeloid cells from PCa tissues, identifying five distinct clusters, including an IL1B + macrophage subset. ( B ) Dot plot showing average expression and detection frequency of selected marker genes across macrophage and dendritic cell (DC) clusters. ( C ) Violin plots illustrating the expression of key pro-inflammatory ( IL1B , TLR2 , CD86 ), anti-inflammatory ( CD163 , MRC1 ), and chemokine ( CXCL16 ) genes across myeloid subsets. ( D ) AUCell-based quantification of M1 and M2 gene signatures across clusters; IL1B + macrophages exhibit the highest M1 signature score. Kruskal-Wallis test, ****p<0.0001. ( E ) CellChat network visualizing outgoing macrophage-derived signals to CD8 + T-cell subsets; IL1B + macrophages prominently interact with CXCR6 + TEff-like CD8 + T cells. ( F ) Bubble plot visualizing the results of ligand–receptor interaction analysis; CXCL16–CXCR6 axis ranks among the strongest predicted signals. ( G ) Gating strategy for the identification of murine bone marrow-derived macrophages (BMDMs) induced with M-CSF. ( H ) Flow cytometry of BMDMs polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by CD80 and CD206 expression. ( I ) Confocal images of THP-1-derived macrophages stained for CD68 after PMA induction. ( J ) Flow cytometry of THP-1-derived macrophages polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by MHC-II and CD206 expression. ( K ) Immunoblots showing higher CXCL16 levels in M1-polarized BMDMs compared with their M2 counterparts. ( L ) ELISA quantification of secreted CXCL16 in the supernatants of M1-polarized and M2-polarized THP-1-derived macrophages. Mann-Whitney U test, **p<0.01. ( M ) Immunoblot analysis demonstrating elevated levels of CXCL16 in M1-polarized THP-1-derived macrophages compared with M2-polarized cells. (N, O). A total of 5×10⁶ TRAMP-C1 cells suspended in 100 µL PBS were subcutaneously implanted into the right flank of 5–6-week-old male WT C57BL/6J mice (n=5 per group). Tumors were harvested at day 35 (early stage) and day 49 (advanced stage) post-inoculation. Flow cytometric analysis of TAMs revealed a significant reduction in the ratio of MHCII + CD206⁻ (M1-like) to MHCII⁻ CD206 + (M2-like) macrophages during tumor progression. Mann-Whitney U test, **p<0.01. ( P ) Multiplex immunohistochemistry of human PCa tissues (GS=3+4 vs GS=5+5) demonstrated spatial proximity between CXCL16 + M1-like macrophages <t>(HLA-DRA</t> + ) and CXCR6 + CD8 + T cells in lower-grade (GS=3+4) tumors, which was largely diminished in high-grade (GS=5+5) lesions. Black arrows indicate matched regions across serial tissue sections. Scale bars: upper panels, 100 µm; lower panels, 40 µm. AUCell, area under the recovery curve; GS, Gleason Score; M-CSF, macrophage colony-stimulating factor; PCa, prostate cancer; PBS, phosphate-buffered saline; TAMs, tumor-associated macrophages.
Rat Anti Mouse Mhc Class Ii Monoclonal, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti mouse mhc class ii monoclonal/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
rat anti mouse mhc class ii monoclonal - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

94
novus biologicals nbp2-21789
Primary antibodies used
Nbp2 21789, supplied by novus biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nbp2-21789/product/novus biologicals
Average 94 stars, based on 1 article reviews
nbp2-21789 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
Bio-Rad mhcii
Modulation of CB2 with SMM-189 globally reduces macrophages and infiltrating monocytes and CD4 T lymphocytes at 4 weeks. Brain immune cells from high cohort rats were isolated from lesioned (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) rat hemispheres at 4 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations from CD45 and CD11b expression and further gated into more distinct populations. Macrophage <t>populations</t> <t>(CD163</t> + CD11b+) were identified from live cells (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 4 weeks. B ) Quantification of CD163 + reveals a global reduction of macrophages from SMM-189 treatment. C ) Representative dot blots of CD45 and CD11b in the unlesioned hemisphere of a vehicle and SMM-189-treated rat. D ) Quantification of the monocyte population as a frequency of all live cells (CD45hiCD11b+). E ) Quantification of microglia (CD45loCD11b+), and microglia MFI of F ) CD11b and G ) <t>MHCII.</t> H ) Representative dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat. I ) Quantification of CD4-expressing T lymphocytes. * p < 0.05
Mhcii, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mhcii/product/Bio-Rad
Average 93 stars, based on 1 article reviews
mhcii - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

91
Cell Signaling Technology Inc mouse anti human rb
Modulation of CB2 with SMM-189 globally reduces macrophages and infiltrating monocytes and CD4 T lymphocytes at 4 weeks. Brain immune cells from high cohort rats were isolated from lesioned (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) rat hemispheres at 4 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations from CD45 and CD11b expression and further gated into more distinct populations. Macrophage <t>populations</t> <t>(CD163</t> + CD11b+) were identified from live cells (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 4 weeks. B ) Quantification of CD163 + reveals a global reduction of macrophages from SMM-189 treatment. C ) Representative dot blots of CD45 and CD11b in the unlesioned hemisphere of a vehicle and SMM-189-treated rat. D ) Quantification of the monocyte population as a frequency of all live cells (CD45hiCD11b+). E ) Quantification of microglia (CD45loCD11b+), and microglia MFI of F ) CD11b and G ) <t>MHCII.</t> H ) Representative dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat. I ) Quantification of CD4-expressing T lymphocytes. * p < 0.05
Mouse Anti Human Rb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human rb/product/Cell Signaling Technology Inc
Average 91 stars, based on 1 article reviews
mouse anti human rb - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

90
Cytek Biosciences apc 188 anti mouse mhc class ii
Modulation of CB2 with SMM-189 globally reduces macrophages and infiltrating monocytes and CD4 T lymphocytes at 4 weeks. Brain immune cells from high cohort rats were isolated from lesioned (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) rat hemispheres at 4 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations from CD45 and CD11b expression and further gated into more distinct populations. Macrophage <t>populations</t> <t>(CD163</t> + CD11b+) were identified from live cells (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 4 weeks. B ) Quantification of CD163 + reveals a global reduction of macrophages from SMM-189 treatment. C ) Representative dot blots of CD45 and CD11b in the unlesioned hemisphere of a vehicle and SMM-189-treated rat. D ) Quantification of the monocyte population as a frequency of all live cells (CD45hiCD11b+). E ) Quantification of microglia (CD45loCD11b+), and microglia MFI of F ) CD11b and G ) <t>MHCII.</t> H ) Representative dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat. I ) Quantification of CD4-expressing T lymphocytes. * p < 0.05
Apc 188 Anti Mouse Mhc Class Ii, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc 188 anti mouse mhc class ii/product/Cytek Biosciences
Average 90 stars, based on 1 article reviews
apc 188 anti mouse mhc class ii - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Proteintech anti mouse fitc mhc class ii antibody
Modulation of CB2 with SMM-189 globally reduces macrophages and infiltrating monocytes and CD4 T lymphocytes at 4 weeks. Brain immune cells from high cohort rats were isolated from lesioned (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) rat hemispheres at 4 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations from CD45 and CD11b expression and further gated into more distinct populations. Macrophage <t>populations</t> <t>(CD163</t> + CD11b+) were identified from live cells (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 4 weeks. B ) Quantification of CD163 + reveals a global reduction of macrophages from SMM-189 treatment. C ) Representative dot blots of CD45 and CD11b in the unlesioned hemisphere of a vehicle and SMM-189-treated rat. D ) Quantification of the monocyte population as a frequency of all live cells (CD45hiCD11b+). E ) Quantification of microglia (CD45loCD11b+), and microglia MFI of F ) CD11b and G ) <t>MHCII.</t> H ) Representative dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat. I ) Quantification of CD4-expressing T lymphocytes. * p < 0.05
Anti Mouse Fitc Mhc Class Ii Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse fitc mhc class ii antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
anti mouse fitc mhc class ii antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


M1-like macrophages secrete CXCL16 and support CXCR6 + CD8 + T-cell recruitment but are progressively lost during PCa progression. ( A ) UMAP plot of tumor-infiltrating myeloid cells from PCa tissues, identifying five distinct clusters, including an IL1B + macrophage subset. ( B ) Dot plot showing average expression and detection frequency of selected marker genes across macrophage and dendritic cell (DC) clusters. ( C ) Violin plots illustrating the expression of key pro-inflammatory ( IL1B , TLR2 , CD86 ), anti-inflammatory ( CD163 , MRC1 ), and chemokine ( CXCL16 ) genes across myeloid subsets. ( D ) AUCell-based quantification of M1 and M2 gene signatures across clusters; IL1B + macrophages exhibit the highest M1 signature score. Kruskal-Wallis test, ****p<0.0001. ( E ) CellChat network visualizing outgoing macrophage-derived signals to CD8 + T-cell subsets; IL1B + macrophages prominently interact with CXCR6 + TEff-like CD8 + T cells. ( F ) Bubble plot visualizing the results of ligand–receptor interaction analysis; CXCL16–CXCR6 axis ranks among the strongest predicted signals. ( G ) Gating strategy for the identification of murine bone marrow-derived macrophages (BMDMs) induced with M-CSF. ( H ) Flow cytometry of BMDMs polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by CD80 and CD206 expression. ( I ) Confocal images of THP-1-derived macrophages stained for CD68 after PMA induction. ( J ) Flow cytometry of THP-1-derived macrophages polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by MHC-II and CD206 expression. ( K ) Immunoblots showing higher CXCL16 levels in M1-polarized BMDMs compared with their M2 counterparts. ( L ) ELISA quantification of secreted CXCL16 in the supernatants of M1-polarized and M2-polarized THP-1-derived macrophages. Mann-Whitney U test, **p<0.01. ( M ) Immunoblot analysis demonstrating elevated levels of CXCL16 in M1-polarized THP-1-derived macrophages compared with M2-polarized cells. (N, O). A total of 5×10⁶ TRAMP-C1 cells suspended in 100 µL PBS were subcutaneously implanted into the right flank of 5–6-week-old male WT C57BL/6J mice (n=5 per group). Tumors were harvested at day 35 (early stage) and day 49 (advanced stage) post-inoculation. Flow cytometric analysis of TAMs revealed a significant reduction in the ratio of MHCII + CD206⁻ (M1-like) to MHCII⁻ CD206 + (M2-like) macrophages during tumor progression. Mann-Whitney U test, **p<0.01. ( P ) Multiplex immunohistochemistry of human PCa tissues (GS=3+4 vs GS=5+5) demonstrated spatial proximity between CXCL16 + M1-like macrophages (HLA-DRA + ) and CXCR6 + CD8 + T cells in lower-grade (GS=3+4) tumors, which was largely diminished in high-grade (GS=5+5) lesions. Black arrows indicate matched regions across serial tissue sections. Scale bars: upper panels, 100 µm; lower panels, 40 µm. AUCell, area under the recovery curve; GS, Gleason Score; M-CSF, macrophage colony-stimulating factor; PCa, prostate cancer; PBS, phosphate-buffered saline; TAMs, tumor-associated macrophages.

Journal: Journal for Immunotherapy of Cancer

Article Title: Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression

doi: 10.1136/jitc-2025-014276

Figure Lengend Snippet: M1-like macrophages secrete CXCL16 and support CXCR6 + CD8 + T-cell recruitment but are progressively lost during PCa progression. ( A ) UMAP plot of tumor-infiltrating myeloid cells from PCa tissues, identifying five distinct clusters, including an IL1B + macrophage subset. ( B ) Dot plot showing average expression and detection frequency of selected marker genes across macrophage and dendritic cell (DC) clusters. ( C ) Violin plots illustrating the expression of key pro-inflammatory ( IL1B , TLR2 , CD86 ), anti-inflammatory ( CD163 , MRC1 ), and chemokine ( CXCL16 ) genes across myeloid subsets. ( D ) AUCell-based quantification of M1 and M2 gene signatures across clusters; IL1B + macrophages exhibit the highest M1 signature score. Kruskal-Wallis test, ****p<0.0001. ( E ) CellChat network visualizing outgoing macrophage-derived signals to CD8 + T-cell subsets; IL1B + macrophages prominently interact with CXCR6 + TEff-like CD8 + T cells. ( F ) Bubble plot visualizing the results of ligand–receptor interaction analysis; CXCL16–CXCR6 axis ranks among the strongest predicted signals. ( G ) Gating strategy for the identification of murine bone marrow-derived macrophages (BMDMs) induced with M-CSF. ( H ) Flow cytometry of BMDMs polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by CD80 and CD206 expression. ( I ) Confocal images of THP-1-derived macrophages stained for CD68 after PMA induction. ( J ) Flow cytometry of THP-1-derived macrophages polarized to M1 (IFN-γ+LPS) or M2 (IL-4) states, assessed by MHC-II and CD206 expression. ( K ) Immunoblots showing higher CXCL16 levels in M1-polarized BMDMs compared with their M2 counterparts. ( L ) ELISA quantification of secreted CXCL16 in the supernatants of M1-polarized and M2-polarized THP-1-derived macrophages. Mann-Whitney U test, **p<0.01. ( M ) Immunoblot analysis demonstrating elevated levels of CXCL16 in M1-polarized THP-1-derived macrophages compared with M2-polarized cells. (N, O). A total of 5×10⁶ TRAMP-C1 cells suspended in 100 µL PBS were subcutaneously implanted into the right flank of 5–6-week-old male WT C57BL/6J mice (n=5 per group). Tumors were harvested at day 35 (early stage) and day 49 (advanced stage) post-inoculation. Flow cytometric analysis of TAMs revealed a significant reduction in the ratio of MHCII + CD206⁻ (M1-like) to MHCII⁻ CD206 + (M2-like) macrophages during tumor progression. Mann-Whitney U test, **p<0.01. ( P ) Multiplex immunohistochemistry of human PCa tissues (GS=3+4 vs GS=5+5) demonstrated spatial proximity between CXCL16 + M1-like macrophages (HLA-DRA + ) and CXCR6 + CD8 + T cells in lower-grade (GS=3+4) tumors, which was largely diminished in high-grade (GS=5+5) lesions. Black arrows indicate matched regions across serial tissue sections. Scale bars: upper panels, 100 µm; lower panels, 40 µm. AUCell, area under the recovery curve; GS, Gleason Score; M-CSF, macrophage colony-stimulating factor; PCa, prostate cancer; PBS, phosphate-buffered saline; TAMs, tumor-associated macrophages.

Article Snippet: Sections were then incubated overnight at 4°C with primary antibodies against CD8 (Abcam, ab17147; 1:200), CXCR6 (Abcam, ab8023; 1:100), CXCL16 (ProteinTech Group, 60123-1-Ig; 1:100), CD68 (Abcam, ab125212; 1:200), iNOS (Abcam, ab3523; 1:200), HLA-DRA (ProteinTech Group, 17221-1-AP; 1:100), CD163 (Abcam, ab182422; 1:200), KLF2 (ABclonal, A16480; 1:200), FOXO1 (ProteinTech Group, 18592-1-AP; 1:100), Granzyme B (Thermo Fisher, MA1-80734; 1:100), α-SMA (Abcam, ab5694; 1:100) and AR (Abcam, ab133273; 1:100).

Techniques: Expressing, Marker, Derivative Assay, Flow Cytometry, Staining, Western Blot, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY, Multiplex Assay, Immunohistochemistry, Saline

IL-10–STAT3–FOXO1 signaling reprograms CXCR6 + CD8 + T cells toward a dysfunctional state. ( A ) Dot plot showing the expression of IL10RA , STAT3 , STAT4 , CXCR6 , and related markers across CD8 + T cell subsets in scRNA-seq data. ( B ) IL-10 pathway activity scores across CD8 + T cell clusters. Kruskal-Wallis test, ****p<0.0001. (C, D) Murine splenic CD8 + T cells cultured in a medium containing anti-CD3 (5 µg/mL), anti-CD28 (5 µg/mL), and IL-2 (10 ng/mL) for 48 hours. Following initial activation, cells were maintained in fresh medium supplemented with IL-2 (10 ng/mL) for an additional 7 days. On day 9, cells were treated with 20 ng/mL murine IL-10, IL-15, or STAT3 inhibitor Stattic (2 µM) for 24 hours. The protein expression of STAT3, p-STATS, FOXO1, KLF2, and CXCR6 was assessed by Western blot analysis. (E, F) Flow cytometry of mouse spleen-derived CD8 + T cells shows preferential expression of IL-10R on CXCR6 + CD8 + T cells, with upregulation observed following TCR stimulation (anti-CD3/CD28+IL-2, day 10), indicating heightened susceptibility to IL-10-mediated signaling. (G–I) Flow cytometry of human peripheral blood mononuclear cell (PBMC) CD8 + T cells from healthy donors similarly demonstrates enhanced IL-10R expression on CXCR6 + CD8 + T cells and its induction on TCR stimulation. ( J ) PCA of bulk RNA-seq. Prostate tissues from Pb-Cre; Pten flox/flox ( T ) and WT mice (n=3/group) were profiled by bulk RNA-seq. PCA separated T (blue) from WT (red) chiefly along PC1 (87.24% variance) and PC2 (5.64%). ( K ) Sample-to-sample distance heatmap. Distance matrix based on transformed expression values shows tight clustering of biological replicates within genotype and clear segregation between T and WT. ( L ) Volcano plot. Differential expression analysis between T and WT (cut-offs |log2FC|≥1.5, FDR<0.05). Points are colored by direction (Up=red; Down=blue). Dashed lines indicate thresholds. Il10 , Mrc1 , Cd163 , and Cxcr6 are highlighted in purple; other selected genes are labeled as indicated. Y-axis shows –log 10 (adjusted p). ( M ) Multiplex immunofluorescence (human prostate). Representative fields from human prostate specimens (n=9). Channels: DAPI (nuclei), CD68 (pan-macrophage), HLA-DRA (M1-like macrophage), CD163 (M2-like macrophage), and IL-10. IL-10 signal is enriched in tumor regions and co-localizes with CD68 + CD163 + macrophages. Scale bar: 20 µm. DAPI, 4′,6-diamidino-2-phenylindole; FDR, false discovery rate; PCA, principal component analysis; scRNA-seq, single-cell RNA sequencing; WT, wild-type.

Journal: Journal for Immunotherapy of Cancer

Article Title: Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression

doi: 10.1136/jitc-2025-014276

Figure Lengend Snippet: IL-10–STAT3–FOXO1 signaling reprograms CXCR6 + CD8 + T cells toward a dysfunctional state. ( A ) Dot plot showing the expression of IL10RA , STAT3 , STAT4 , CXCR6 , and related markers across CD8 + T cell subsets in scRNA-seq data. ( B ) IL-10 pathway activity scores across CD8 + T cell clusters. Kruskal-Wallis test, ****p<0.0001. (C, D) Murine splenic CD8 + T cells cultured in a medium containing anti-CD3 (5 µg/mL), anti-CD28 (5 µg/mL), and IL-2 (10 ng/mL) for 48 hours. Following initial activation, cells were maintained in fresh medium supplemented with IL-2 (10 ng/mL) for an additional 7 days. On day 9, cells were treated with 20 ng/mL murine IL-10, IL-15, or STAT3 inhibitor Stattic (2 µM) for 24 hours. The protein expression of STAT3, p-STATS, FOXO1, KLF2, and CXCR6 was assessed by Western blot analysis. (E, F) Flow cytometry of mouse spleen-derived CD8 + T cells shows preferential expression of IL-10R on CXCR6 + CD8 + T cells, with upregulation observed following TCR stimulation (anti-CD3/CD28+IL-2, day 10), indicating heightened susceptibility to IL-10-mediated signaling. (G–I) Flow cytometry of human peripheral blood mononuclear cell (PBMC) CD8 + T cells from healthy donors similarly demonstrates enhanced IL-10R expression on CXCR6 + CD8 + T cells and its induction on TCR stimulation. ( J ) PCA of bulk RNA-seq. Prostate tissues from Pb-Cre; Pten flox/flox ( T ) and WT mice (n=3/group) were profiled by bulk RNA-seq. PCA separated T (blue) from WT (red) chiefly along PC1 (87.24% variance) and PC2 (5.64%). ( K ) Sample-to-sample distance heatmap. Distance matrix based on transformed expression values shows tight clustering of biological replicates within genotype and clear segregation between T and WT. ( L ) Volcano plot. Differential expression analysis between T and WT (cut-offs |log2FC|≥1.5, FDR<0.05). Points are colored by direction (Up=red; Down=blue). Dashed lines indicate thresholds. Il10 , Mrc1 , Cd163 , and Cxcr6 are highlighted in purple; other selected genes are labeled as indicated. Y-axis shows –log 10 (adjusted p). ( M ) Multiplex immunofluorescence (human prostate). Representative fields from human prostate specimens (n=9). Channels: DAPI (nuclei), CD68 (pan-macrophage), HLA-DRA (M1-like macrophage), CD163 (M2-like macrophage), and IL-10. IL-10 signal is enriched in tumor regions and co-localizes with CD68 + CD163 + macrophages. Scale bar: 20 µm. DAPI, 4′,6-diamidino-2-phenylindole; FDR, false discovery rate; PCA, principal component analysis; scRNA-seq, single-cell RNA sequencing; WT, wild-type.

Article Snippet: Sections were then incubated overnight at 4°C with primary antibodies against CD8 (Abcam, ab17147; 1:200), CXCR6 (Abcam, ab8023; 1:100), CXCL16 (ProteinTech Group, 60123-1-Ig; 1:100), CD68 (Abcam, ab125212; 1:200), iNOS (Abcam, ab3523; 1:200), HLA-DRA (ProteinTech Group, 17221-1-AP; 1:100), CD163 (Abcam, ab182422; 1:200), KLF2 (ABclonal, A16480; 1:200), FOXO1 (ProteinTech Group, 18592-1-AP; 1:100), Granzyme B (Thermo Fisher, MA1-80734; 1:100), α-SMA (Abcam, ab5694; 1:100) and AR (Abcam, ab133273; 1:100).

Techniques: Expressing, Activity Assay, Cell Culture, Activation Assay, Western Blot, Flow Cytometry, Derivative Assay, RNA Sequencing, Transformation Assay, Quantitative Proteomics, Labeling, Multiplex Assay, Immunofluorescence, Single Cell

Primary antibodies used

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: The antioxidant glutathione protects against enteric neuron death in situ, but its depletion is protective during colitis

doi: 10.1152/ajpgi.00165.2017

Figure Lengend Snippet: Primary antibodies used

Article Snippet: Rat anti-MHC II , 1:200 , Novus Biologicals, Littleton, CO , NBP2-21789.

Techniques:

Modulation of CB2 with SMM-189 globally reduces macrophages and infiltrating monocytes and CD4 T lymphocytes at 4 weeks. Brain immune cells from high cohort rats were isolated from lesioned (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) rat hemispheres at 4 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations from CD45 and CD11b expression and further gated into more distinct populations. Macrophage populations (CD163 + CD11b+) were identified from live cells (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 4 weeks. B ) Quantification of CD163 + reveals a global reduction of macrophages from SMM-189 treatment. C ) Representative dot blots of CD45 and CD11b in the unlesioned hemisphere of a vehicle and SMM-189-treated rat. D ) Quantification of the monocyte population as a frequency of all live cells (CD45hiCD11b+). E ) Quantification of microglia (CD45loCD11b+), and microglia MFI of F ) CD11b and G ) MHCII. H ) Representative dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat. I ) Quantification of CD4-expressing T lymphocytes. * p < 0.05

Journal: Journal of Neuroinflammation

Article Title: Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy

doi: 10.1186/s12974-024-03221-5

Figure Lengend Snippet: Modulation of CB2 with SMM-189 globally reduces macrophages and infiltrating monocytes and CD4 T lymphocytes at 4 weeks. Brain immune cells from high cohort rats were isolated from lesioned (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) rat hemispheres at 4 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations from CD45 and CD11b expression and further gated into more distinct populations. Macrophage populations (CD163 + CD11b+) were identified from live cells (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 4 weeks. B ) Quantification of CD163 + reveals a global reduction of macrophages from SMM-189 treatment. C ) Representative dot blots of CD45 and CD11b in the unlesioned hemisphere of a vehicle and SMM-189-treated rat. D ) Quantification of the monocyte population as a frequency of all live cells (CD45hiCD11b+). E ) Quantification of microglia (CD45loCD11b+), and microglia MFI of F ) CD11b and G ) MHCII. H ) Representative dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat. I ) Quantification of CD4-expressing T lymphocytes. * p < 0.05

Article Snippet: In brief, endogenous peroxidase was quenched with 3% hydrogen peroxide, blocked with 8% normal serum, avidin (Vector Cat#SP-2001) and 0.1% Triton-X and incubated overnight at 4°C with biotin (Vectorlabs Cat#SP-2001), normal serum and primary antibodies specific for Asyn (Clone 4B12; BioLegend Cat# 807801, RRID: AB_2564730), pSer129 Asyn (Clone EP1536Y; Abcam Cat# ab51253, RRID: AB_869973), CD68 (Bio-Rad Cat# MCA341R, RRID: AB_2291300), MHCII (Bio-Rad Cat# MCA46GA, RRID: AB_567369), and CD163 (Bio-Rad Cat# MCA342A, RRID: AB_2074557).

Techniques: Isolation, Flow Cytometry, Expressing

Modulation of CB2 with SMM-189 promotes innate immune cell activation and altered infiltration of T lymphocytes in the brain at 8 weeks. Brain immune cells from high cohort rats were isolated from lesioned- (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) hemispheres at 8 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations using CD45 and CD11b expression and further gated into more distinct populations (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 8 weeks. B ) Quantification of monocyte (CD45hiCD11b+) and C ) MHCII-expressing classical monocyte (MHCII + CD43-) frequencies. D ) Analysis of microglia (CD45loCD11b+) and microglia MFI of E ) MHCII F ) CD172a and G ) CD11b. H ) Dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat at 8 weeks. I ) Quantification of CD4-expressing and J ) CD8-expressing T cells. * p < 0.05, ** p < 0.01

Journal: Journal of Neuroinflammation

Article Title: Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy

doi: 10.1186/s12974-024-03221-5

Figure Lengend Snippet: Modulation of CB2 with SMM-189 promotes innate immune cell activation and altered infiltration of T lymphocytes in the brain at 8 weeks. Brain immune cells from high cohort rats were isolated from lesioned- (+ AAV-human Asyn) and unlesioned (-AAV-human Asyn) hemispheres at 8 weeks and flow cytometry analysis conducted to identify monocyte, lymphocyte and microglia populations using CD45 and CD11b expression and further gated into more distinct populations (see Figure ). A ) Representative dot blots of CD163 + macrophages in the unlesioned hemisphere of a vehicle and SMM-189-treated rat at 8 weeks. B ) Quantification of monocyte (CD45hiCD11b+) and C ) MHCII-expressing classical monocyte (MHCII + CD43-) frequencies. D ) Analysis of microglia (CD45loCD11b+) and microglia MFI of E ) MHCII F ) CD172a and G ) CD11b. H ) Dot blots of CD3 + lymphocytes stratified by CD4 and CD8 populations in the lesion hemisphere of a vehicle and SMM-189-treated rat at 8 weeks. I ) Quantification of CD4-expressing and J ) CD8-expressing T cells. * p < 0.05, ** p < 0.01

Article Snippet: In brief, endogenous peroxidase was quenched with 3% hydrogen peroxide, blocked with 8% normal serum, avidin (Vector Cat#SP-2001) and 0.1% Triton-X and incubated overnight at 4°C with biotin (Vectorlabs Cat#SP-2001), normal serum and primary antibodies specific for Asyn (Clone 4B12; BioLegend Cat# 807801, RRID: AB_2564730), pSer129 Asyn (Clone EP1536Y; Abcam Cat# ab51253, RRID: AB_869973), CD68 (Bio-Rad Cat# MCA341R, RRID: AB_2291300), MHCII (Bio-Rad Cat# MCA46GA, RRID: AB_567369), and CD163 (Bio-Rad Cat# MCA342A, RRID: AB_2074557).

Techniques: Activation Assay, Isolation, Flow Cytometry, Expressing